Expertise in
23
conditions

Giampiero Girolomoni

Verona, IT 
Expertise in
23
conditions
Verona, IT 

Overview

Giampiero Girolomoni practices practicing medicine in Verona, Italy.

Girolomoni is highly rated in 23 conditions, according to our data. Their clinical expertise encompasses Plaque Psoriasis, Atopic Dermatitis, Psoriasis, Psoriatic Arthritis, and Kidney Transplant.

They are actively involved in clinical research, co-authoring 463 peer reviewed articles and participating in 2 clinical trials.

Locations

Verona, Italy
Other Locations
Milan, Italy

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Phase 3 Multicenter, Double-Blind Study to Evaluate the Long-Term Safety and Efficacy of Baricitinib in Adult Patients With Atopic Dermatitis
A Phase 3 Multicenter, Double-Blind Study to Evaluate the Long-Term Safety and Efficacy of Baricitinib in Adult Patients With Atopic Dermatitis
Enrollment Status: Completed
Publish Date: September 03, 2024
Intervention Type: Drug
Study Drug: Baricitinib
Study Phase: Phase 3
A Phase 3, Multicenter, Double-Blind, Randomized, Placebo-Controlled Study Evaluating the Safety and Efficacy of Baricitinib in Combination With Topical Corticosteroids in Adult Patients With Moderate-to-Severe Atopic Dermatitis Who Have Experienced Failure to Cyclosporine or Are Intolerant to, or Have Contraindication to, Cyclosporine
A Phase 3, Multicenter, Double-Blind, Randomized, Placebo-Controlled Study Evaluating the Safety and Efficacy of Baricitinib in Combination With Topical Corticosteroids in Adult Patients With Moderate-to-Severe Atopic Dermatitis Who Have Experienced Failure to Cyclosporine or Are Intolerant to, or Have Contraindication to, Cyclosporine
Enrollment Status: Completed
Publish Date: May 14, 2024
Intervention Type: Drug
Study Drugs: Baricitinib, Corticosteroid
Study Phase: Phase 3
View 1 Less Clinical Trial

462 Total Publications

Switchback from biosimilar tumor necrosis factor-alpha inhibitors to reference medicines: a review.
Switchback from biosimilar tumor necrosis factor-alpha inhibitors to reference medicines: a review.
Journal: Expert review of clinical immunology
Published: September 03, 2026

Frequently Asked Questions about Giampiero Girolomoni

Is Giampiero Girolomoni a top-rated expert for Plaque Psoriasis?

MediFind is an objective health platform that identifies experts based on real-world data. Giampiero Girolomoni is classified as an Elite expert for Plaque Psoriasis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Giampiero Girolomoni participate in research or clinical trials?

Yes. Giampiero Girolomoni has published 462 articles and abstracts on conditions like Plaque Psoriasis. You can view a list of Giampiero Girolomoni's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Girolomoni's expertise for a condition
ConditionClose
View All 19 Advanced Conditions
View All 93 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile